Clinical Trial

Treatments for Open-Angle Glaucoma or Ocular Hypertension

Study Description

Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension

This study will evaluate the intraocular pressure-lowering effect and safety of Bimatoprost SR compared with selective laser trabeculoplasty in patients with open-angle glaucoma or ocular hypertension who are not adequately managed with topical IOP-lowering medication.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Drug - Bimatoprost SR

Up to three Bimatoprost SR Dose A administrations at Day 4, Weeks 16 and 32 (Stage 1) or two Bimatoprost SR Dose B administrations at Day 4 and Week 16 (Stage 2).

Drug - Sham Bimatoprost SR

Up to three Sham Bimatoprost SR administrations at Day 4, Weeks 16 and 32 (Stage 1) or two Sham Bimatoprost SR administrations at Day 4 and Week 16 (Stage 2).

Procedure - Selective Laser Trabeculoplasty

Selective Laser Trabeculoplasty administered on Day 1.

Procedure - Sham Selective Laser Trabeculoplasty

Sham Selective Laser Trabeculoplasty administered on Day 1.

Additional Information

Official Study Title

A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension

Clinical Trial ID

NCT02507687

ParticipAid ID

QbY0Wa